Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, Lalmohan Maji, Prasad Sanjay Dhiwar, B V Manjushree, Mayavan Viji
Topics & Concepts
Poly ADP ribose polymeraseDNA repairPolymeraseSynthetic lethalityDNA damageChemistryOlaparibPharmacologyDNACancer researchBiochemistryBiologyPARP inhibition in cancer therapyIntegrated Circuits and Semiconductor Failure AnalysisDNA Repair Mechanisms